Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kingworld Medicines Group Ltd. ( (HK:1110) ) has shared an update.
Kingworld Medicines Group Ltd. has announced a board meeting scheduled for August 27, 2025, to discuss and approve the unaudited interim results for the first half of the year and consider an interim dividend. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and potential returns, impacting its market positioning and shareholder value.
More about Kingworld Medicines Group Ltd.
Kingworld Medicines Group Ltd. operates in the pharmaceutical industry, focusing on the distribution and retail of medical and healthcare products. The company is engaged in providing a range of pharmaceutical products and services, catering to various market needs.
Average Trading Volume: 1,167,681
Technical Sentiment Signal: Buy
Current Market Cap: HK$351.8M
Find detailed analytics on 1110 stock on TipRanks’ Stock Analysis page.